Cloricromen

Cloricromen
Clinical data
ATC code	B01AC02 (WHO) ;
Identifiers
	IUPAC name Ethyl 2-(8-chloro-3-(2-(diethylamino)ethyl)-4-methyl-2-oxo-2H-chromen-7-yloxy)acetate;
CAS Number	68206-94-0;
PubChem CID	68876;
ChemSpider	62108 ;
UNII	B9454PE93C;
KEGG	D07139 ;
ChEMBL	ChEMBL255066 ;
CompTox Dashboard (EPA)	DTXSID2048373 ;
ECHA InfoCard	100.164.003
Chemical and physical data
Formula	C20H26ClNO5
Molar mass	395.88 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(OCC)COc2ccc\1c(OC(=O)/C(=C/1C)CCN(CC)CC)c2Cl;
	InChI InChI=1S/C20H26ClNO5/c1-5-22(6-2)11-10-15-13(4)14-8-9-16(26-12-17(23)25-7-3)18(21)19(14)27-20(15)24/h8-9H,5-7,10-12H2,1-4H3 ; Key:GYNNRVJJLAVVTQ-UHFFFAOYSA-N ;
	(verify)

Cloricromen is a platelet aggregation inhibitor.^[1]

References[edit]

^ Orefice G, Grasso A, Fazio N, Del Vecchio G, Volpe G, Coppola M, D'Alessio A, Carrieri PB (1994). "No effect of cloricromen on some coagulation parameters in patients with ischaemic cerebrovascular disease". The Journal of International Medical Research. 22 (5): 287–91. doi:10.1177/030006059402200506. PMID 7867874. S2CID 36081514.

This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it.